XML 44 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Nature of Operations and Liquidity - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 30, 2023
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Organization And Nature Of Operations [Line Items]                    
Net income   $ 2,856 $ 4,538 $ 9,935 $ 7,510 $ 3,770 $ 4,217 $ 17,300    
Net cash used in operating activities               883 $ (22,532)  
Accumulated deficit   73,354           73,354   $ 85,538
Cash and cash equivalents   $ 15,866           $ 15,866   $ 33,509
Gyre | Gyre Pharmaceuticals                    
Organization And Nature Of Operations [Line Items]                    
Minority interest ownership indirectly holds 65.20%